Nonsurgical UGN-102 for recurrent LG-IR-NMIBC: Pooled efficacy and safety from phase 2 and 3 trials

Urologic Oncology: Seminars and Original Investigations · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles